3Pappas G, Akritidis N, Bosikovski M and Tsianos E. Brocellosis [ J ]. N Engl J Med 2005,352:2325 - 2336.
4Pappas G, Bosikovski M, Akritidis N. Mastora M, Krteva L and Tsianos E. Brocellosis and the respiratory system [ J ]. Clin Infect Dis. 2003,37 (7) :95 - 99.
5Akritidis N, Tzivras M, Delladetsima I, Stefanaki S, Moutsopoulos HM, Pappas G. The liver in Brucellosis [ J]. Clin Gastroenterol Heptol 2007 May 4 [ Epub ahead of print].
6Ustun I, Ozcakar L, Arda N, Duranay M, Bayrak E, Duman K, Atabay M, Cakal BE, Altundag K, Guler S [ J]. South Med J 2005,98(12) :1216.
7Pappas G, Siozopoulou V, Akritidis N, Falagas ME. Doxycycline- rifampicin : physicians inferior choice in brucellosis or how convenience reigns over science [ J ]. J Infect 2007,54( 5 ) :459 - 462.
8Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis : a randomized clinical trial [ J ]. BMC Infect Dis 2004,4 : 18.
9Dizbay M, Kilic S, Hizel K, Arman D. Tigecycline: its potential for treatment of brucellosis [ J ]. Scand J Infect Dis 2007,39 (5) :432 - 434.
10Sulushash Mizanbayevaa, Henk L. Smitsb, Katya Zhalilovaa, Theresia H. Abdoelb, The evaluation of a user-friendly lateral flow assay for the serodiagnosis of human brucellosis in Kazakhstan. Diagnostic Microbiology and Infectious Disease 2009,65 : 14 -20.
